13972139 · Active · incorporated 4 years, 4 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series A
IsomAb is a biotechnology company developing isoform-specific antibodies for treating life-limiting diseases, including a therapeutic antibody for coronary artery disease.
See the complete cap table with every shareholder, founder tags, dilution across 26 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.